These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24974366)

  • 1. Peer, professional, and public: an analysis of the drugs policy advocacy community in Europe.
    O'Gorman A; Quigley E; Zobel F; Moore K
    Int J Drug Policy; 2014 Sep; 25(5):1001-8. PubMed ID: 24974366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Civil society involvement in harm reduction drug policy: reflections on the past, expectations for the future.
    O'Gorman A; Schatz E
    Harm Reduct J; 2021 Feb; 18(1):17. PubMed ID: 33568156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Governance in EU illicit drugs policy.
    Edwards C; Galla M
    Int J Drug Policy; 2014 Sep; 25(5):942-7. PubMed ID: 25060612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US Public Health Agency involvement in youth-focused illicit drug policy, planning, and prevention at the local level, 1999-2003.
    McBride DC; Terry-McElrath YM; VanderWaal CJ; Chriqui JF; Myllyluoma J
    Am J Public Health; 2008 Feb; 98(2):270-7. PubMed ID: 18172140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partnerships and communities in English drug policy: the challenge of deprivation.
    Macgregor S; Thickett A
    Int J Drug Policy; 2011 Nov; 22(6):478-90. PubMed ID: 21890338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Civil society-a leader in HIV prevention and tobacco control.
    Malinowska-Sempruch K; Bonnell R; Hoover J
    Drug Alcohol Rev; 2006 Nov; 25(6):625-32. PubMed ID: 17132578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-level governance: The way forward for European illicit drug policy?
    Chatwin C
    Int J Drug Policy; 2007 Dec; 18(6):494-502. PubMed ID: 18061875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. eEurope 2002: Quality Criteria for Health Related Websites.
    Commission of the European Communities, Brussels
    J Med Internet Res; 2002 Dec; 4(3):E15. PubMed ID: 12554546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction in Europe: a framework for civil society-led monitoring.
    Rigoni R; Tammi T; van der Gouwe D; Schatz E
    Harm Reduct J; 2021 Jan; 18(1):3. PubMed ID: 33407566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circus monkeys or change agents? Civil society advocacy for HIV/AIDS in adverse policy environments.
    Spicer N; Harmer A; Aleshkina J; Bogdan D; Chkhatarashvili K; Murzalieva G; Rukhadze N; Samiev A; Walt G
    Soc Sci Med; 2011 Dec; 73(12):1748-55. PubMed ID: 22036298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging mental health strategy of the European Union: a multi-level work-in-progress.
    Kelly BD
    Health Policy; 2008 Jan; 85(1):60-70. PubMed ID: 17643547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
    Williamson RT; Rodd J
    BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is good governance in the context of drug policy?
    Singleton N; Rubin J
    Int J Drug Policy; 2014 Sep; 25(5):935-41. PubMed ID: 24768218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sector cooperation in health-enhancing physical activity policymaking: more potential than achievements?
    Hämäläinen RM; Aro AR; Lau CJ; Rus D; Cori L; Syed AM;
    Health Res Policy Syst; 2016 Apr; 14(1):33. PubMed ID: 27129850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making drug policy together: reflections on evidence, engagement and participation.
    Roberts M
    Int J Drug Policy; 2014 Sep; 25(5):952-6. PubMed ID: 24882708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
    Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer survivorship advocacy.
    Haylock PJ
    Semin Oncol Nurs; 2015 Feb; 31(1):79-85. PubMed ID: 25636399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public health within the EU policy space: a qualitative study of Organized Civil Society (OCS) and the Health in All Policies (HiAP) approach.
    Franklin PK
    Public Health; 2016 Jul; 136():29-34. PubMed ID: 27062067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Civil society organisations' roles in health development in Vietnam: HIV as a case study.
    Hoang TA
    Glob Public Health; 2013; 8 Suppl 1():S92-103. PubMed ID: 23822631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.